South Korea Stem Cell Therapy Market to 2032
Overview
The South Korea Stem Cell Therapy Market is expected to reach a 138.18 USD Million by 2032 and is projected to grow at a CAGR of 16.03% from 2025 to 2032.
Revenue, 2024 (USD Million)
58.77
Forecast, 2032 (USD Million)
138.18
CAGR, 2024 - 2032
16.03%
Report Coverage
South Korea
South Korea Stem Cell Therapy Market 2018-2032 USD Million
South Korea Stem Cell Therapy Market, Key Findings (2025-2032)
Market Growth and Projections:
- Market Size (2024): 58.77 USD Million
- Projected Market Size (2032): 138.18 USD Million
- CAGR (2025-2032): 16.03%
Key Findings of South Korea Stem Cell Therapy Market
- The South Korea Stem Cell Therapy Market was valued at 58.77 USD Million in 2024.
- The South Korea Stem Cell Therapy Market is likely to grow at a CAGR of 16.03% during the forecast period of 2024 to 2032.
- In 2024, the Largest segment Direct Tender in Distribution Channel Segment accounted for the largest share of the market with a revenue of 58.77 USD Million
- The fastest growing segment Cardiovascular Diseases in Applications Segment grew Fastest with a CAGR of 19.03% during the forecast period from 2024 to 2032.
South Korea Stem Cell Therapy Market Scope
South Korea Stem Cell Therapy Market Segmentation & Scope
Distribution Channel
- Third Party Distributors
- Direct Tender
End User
- Others
- Services Companies
- Therapeutic Companies
- Hospitals and Surgical Centers
Applications
- Surgeries
- Acute Graft-Versus-Host Disease (AGVHD)
- Wounds and Injuries
- Gastrointestinal Diseases
- Musculoskeletal Disorders
- Other Applications
- Cardiovascular Diseases
Type
- Allogeneic Stem Cell Therapy
- Autologous Stem Cell Therapy
Product Type
- Others
- Adipose Tissue Derived Mesenchymal Stem Cells
- Bone Marrow Derived Mesenchymal Stem Cells
- Placental/Umbilical Stem Cell
South Korea Stem Cell Therapy Market Data Coverage Insights
| Study Period | 2024-2032 |
| Base Year | 2021 |
| Unit | Revenue in USD Million |
| Market Value in 2024 | 58.77 USD Million |
| Market Value in 2032 | 138.18 USD Million |
| CAGR (2025-2032) | 16.03% |
| Historic Data | 2016-2023 |
| Market Segments Covered | Distribution Channel,End User,Applications,Type,Product Type |
Regional Insights:
-
Leading Market (2024-2032): South Korea, leading in terms of revenue 58.77 USD Million in 2024
- Key Country: South Korea, leading in terms of revenue with value of 58.77 USD Million in 2024.
Segments and Scope
-
South Korea Stem Cell Therapy Market to 2032, By Distribution Channel
- Direct Tender is the largest segment in South Korea Stem Cell Therapy Market to 2032 with a revenue of 58.77 USD Million in the year 2024.
- Direct Tender is the Fastest growing segment in South Korea Stem Cell Therapy Market to 2032 with a Growth rate of 16.03 % in forecast period 2025-2032.
-
South Korea Stem Cell Therapy Market to 2032, By End User
- Hospitals and Surgical Centers is the largest segment in South Korea Stem Cell Therapy Market to 2032 with a revenue of 48.43 USD Million in the year 2024.
- Hospitals and Surgical Centers is the Fastest growing segment in South Korea Stem Cell Therapy Market to 2032 with a Growth rate of 16.06 % in forecast period 2025-2032.
-
South Korea Stem Cell Therapy Market to 2032, By Applications
- Cardiovascular Diseases is the largest segment in South Korea Stem Cell Therapy Market to 2032 with a revenue of 21.02 USD Million in the year 2024.
- Cardiovascular Diseases is the Fastest growing segment in South Korea Stem Cell Therapy Market to 2032 with a Growth rate of 19.03 % in forecast period 2025-2032.
-
South Korea Stem Cell Therapy Market to 2032, By Type
- Autologous Stem Cell Therapy is the largest segment in South Korea Stem Cell Therapy Market to 2032 with a revenue of 41.65 USD Million in the year 2024.
- Autologous Stem Cell Therapy is the Fastest growing segment in South Korea Stem Cell Therapy Market to 2032 with a Growth rate of 16.20 % in forecast period 2025-2032.
-
South Korea Stem Cell Therapy Market to 2032, By Product Type
- Placental/Umbilical Stem Cell is the largest segment in South Korea Stem Cell Therapy Market to 2032 with a revenue of 28.83 USD Million in the year 2024.
- Bone Marrow Derived Mesenchymal Stem Cells is the Fastest growing segment in South Korea Stem Cell Therapy Market to 2032 with a Growth rate of 14.05 % in forecast period 2025-2032.
South Korea Stem Cell Therapy Market Company Share Analysis
| Company Name |
|
||
| Orthofix US LLC. | |||
| Osiris Healthcare | |||
| JCR Pharmaceuticals Co., Ltd. | |||
| The Future of Biotechnology, MEDIPOST | |||
| Takeda Pharmaceutical Company Limited | |||
South Korea Stem Cell Therapy Market Geographical Sales Distribution, 2018-2032 USD Million
South Korea Stem Cell Therapy Market Company Profiling
Industry Related Reports
Frequently Asked Questions
The South Korea Stem Cell Therapy Market is segmented based on Segmentation Distribution Channel,End User,Applications,Type,Product Type.
South Korea Stem Cell Therapy Market was valued at USD 58.77(Revenue in USD Million) in 2021.
South Korea Stem Cell Therapy Market is projected to grow at a CAGR of 16.03% during the forecast period of 2024 to 2032.
The Direct Tender segment is expected to dominate the South Korea Stem Cell Therapy Market, holding a largest market share of 58.77 USD Million in 2024
South Korea Stem Cell Therapy Market Scope
South Korea Stem Cell Therapy Market Segmentation & Scope
Distribution Channel
- Third Party Distributors
- Direct Tender
End User
- Others
- Services Companies
- Therapeutic Companies
- Hospitals and Surgical Centers
Applications
- Surgeries
- Acute Graft-Versus-Host Disease (AGVHD)
- Wounds and Injuries
- Gastrointestinal Diseases
- Musculoskeletal Disorders
- Other Applications
- Cardiovascular Diseases
Type
- Allogeneic Stem Cell Therapy
- Autologous Stem Cell Therapy
Product Type
- Others
- Adipose Tissue Derived Mesenchymal Stem Cells
- Bone Marrow Derived Mesenchymal Stem Cells
- Placental/Umbilical Stem Cell
Frequently Asked Questions
The South Korea Stem Cell Therapy Market is segmented based on Segmentation Distribution Channel,End User,Applications,Type,Product Type.
South Korea Stem Cell Therapy Market was valued at USD 58.77(Revenue in USD Million) in 2021.
South Korea Stem Cell Therapy Market is projected to grow at a CAGR of 16.03% during the forecast period of 2024 to 2032.
The estimated market value of the South Korea Stem Cell Therapy Market for final year is USD 138.18 (USD Million).
South Korea Stem Cell Therapy Market Company Profiling
Frequently Asked Questions
The South Korea Stem Cell Therapy Market is segmented based on Segmentation Distribution Channel,End User,Applications,Type,Product Type.
South Korea Stem Cell Therapy Market was valued at USD 58.77(Revenue in USD Million) in 2021.
South Korea Stem Cell Therapy Market is projected to grow at a CAGR of 16.03% during the forecast period of 2024 to 2032.
The estimated market value of the South Korea Stem Cell Therapy Market for final year is USD 138.18 (USD Million).
HAVE A QUESTION?
Get expert advice on the right strategy for your business at no cost. We also offer customized subscription plans and affordable discounts for startups and universities.